JASON ROY: Open Payments
NPI 1558321133 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,208 in 192 payments from 26 companies in 2025. Trend: 2023 $22,513 · 2024 $27,024 · 2025 $38,208
Honoraria: $17,500Consulting: $8,296Food & beverage: $6,723Speaker / faculty: $3,645Travel & lodging: $2,033Education: $10
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 24 | $18,983 |
| Madrigal Pharmaceuticals | 33 | $8,713 |
| GENZYME CORPORATION | 11 | $4,666 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 27 | $2,664 |
| ABBVIE INC. | 33 | $803 |
| Janssen Biotech, Inc. | 7 | $367 |
| Phathom Pharmaceuticals, Inc. | 3 | $244 |
| Celltrion USA Inc. | 7 | $218 |
| Regeneron Healthcare Solutions, Inc. | 3 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $181 |
Products named: RELTONE 200 MG, REZDIFFRA, TRULANCE, XIFAXAN, TREMFYA, DUPIXENT, VOQUEZNA, RINVOQ.
Industry payments across FL — which companies pay providers there.
